HIF1A and neoplasm: Mechanistically, hypoxic microenvironments activate proline metabolism, resulting in the accumulation of hydroxyproline that promotes HCC tumor progression and induces sorafenib resistance by modulating hypoxia-inducible factor 1-alpha (HIF1α)84.